FY26 RECOMPETE OF THE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) REQUIREMENT WITH THE INCLUSION OF THE NEW ELECTRO-THERAPEUTIC MODALITIES FOR PAIN MANAGEMENT (ETMPM) REQUIREMENT.

Request For Information (RFI)

From:

Department of Veterans Affairs (VA)
Veterans Health Administration (VHA)
National Prosthetic & Sensory Aids Service (PSAS)

National Acquisition Center (NAC)

Commodities & Services Acquisition Service (CSAS)

Subject:

FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Requirement with the inclusion of the new Electro-Therapeutic Modalities for Pain Management (ETMPM) Requirement.

Executive Summary:

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), is initiating market research in preparation for the Fiscal Year 2026 (FY26) procurement cycle for the Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) Units and Accessories. This procurement effort represents a significant modernization and expansion of the VA’s national non-opioid pain-management programs. This procurement effort consolidates the requirements from the legacy contract number 36C79122D0005, which is currently suppling the TENS units and accessories, and it expands the product line to include Interferential Current (IFC) units, Short Wave Diathermy units, Neuromodulation devices, and associated electrodes, applicators, batteries, chargers, cables, and clinical-use accessories. The expanded scope of this procurement effort supports VHA’s ongoing transition toward comprehensive, evidence-based, non-pharmacological pain management solutions accessible across all Veterans Integrated Services Networks (VISNs), 168 Veterans Affairs Medical Centers (VAMCs), and more than 1,000 outpatient clinics and federal partner sites. The key objectives of this procurement are:

• Ensure uninterrupted, nationwide availability of ETMPM and TENS devices across all VA facilities.
• Standardize clinical equipment to promote consistency of care, safety, and treatment outcomes for Veterans.
• Establish stable, volume-based Firm-Fixed-Price (FFP) Indefinite-Delivery/Indefinite-Quantity (IDIQ) contracts to secure predictable pricing across the full contract lifecycle.
• Improve supply chain efficiency through centralized distribution at the Denver Logistics Center (DLS) and electronic order processing via ROES.
• Expand product availability to include device types supporting multiple modalities of non-opioid pain management.
• Reduce program risk by eliminating rental, lease, subscription, or usage-based business models that conflict with VA acquisition regulations.
• Maintain Veteran safety through FDA-compliant devices, OEM warranty standards, and strict prohibition of gray-market goods.

Contract Line Item Numbers (CLINs):

The anticipated FY26 solicitation will include the following CLINs:

• CLIN X001 – Transcutaneous Electrical Nerve Stimulation (TENS) Unit and Accessories;

• CLIN X002 – 2” x 2” Electrode Pads;

• CLIN X003 – 2” x 4” Electrode Pads;

• CLIN X004 – 2” x 2” Hypoallergenic Electrode Pads;

• CLIN X005 – 2” x 4” Hypoallergenic Electrode Pads;

• CLIN X006 – Interferential Current (IFC) Unit and Accessories;

• CLIN X007 – Short Wave Diathermy Unit and Accessories; and

• CLIN X008 – Neuromodulation Unit and Accessories

Question For Industry:

The Government is respectfully requesting all industry participants who are interested in this requirement and likely to be prospective Offerors to the resultant solicitation for this requirement to respond to the following questions:

1. HCPCS Utilization: What is your assigned Healthcare Common Procedure Coding System (HCPC) utilization for your devices that you intend to offer to the Government for purchase for CLINs X001, X006, X007, and X008?
2. CMS‑Assigned HCPCS Codes: What is your assigned Centers for Medicare & Medicaid Services (CMS) HCPC for your devices that you intend to offer to the Government for purchase for CLINs X001, X006, X007, and X008?
3. If No CMS Assignment Exists: If no assignment, what HCPC code do you see most often utilized for your devices that you intend to offer to the Government for purchase for CLINs X001, X006, X007, and X008?
4. Anticipated Product Delivery Lead‑Times: The Government must complete solicitation development, perform proposal evaluations, and make source selection decisions, and execute the resultant contracts for this requirement prior to expiration of legacy contract number 36C79122D0005 on January 19, 2027.What are your organization’s standard commercial delivery lead‑times? If awarded a contract under this program, what delivery lead‑time will be required from the date of award to first delivery to the VA’s Denver Logistics Center (DLS) in Golden, Colorado?

Additional Information:

• Respondents to this RFI shall not submit proposals, pricing, or quotes at this time;
• This RFI does not obligate the Government to issue a solicitation or award any contract for this requirement;
• Responding to an RFI is a voluntary action taken by the Respondent, therefore, the Government will not reimburse Respondents for any costs incurred associated with preparing a response to this RFI; and  
• Respondents to this RFI shall not submit to the Government any proprietary or classified information under any circumstances.

Disclaimer:

This Presolicitation Notice is issued solely for market research purposes and informational planning and strategy. It does not constitute a solicitation or a promise to issue a solicitation. No contract award will result from this notice.

Government Designated Point of Contact:

John Overstake
Contract Specialist
Department of Veterans Affairs
Email: john.overstake@va.gov

Phone: (720) 497-2304

RFI Respondent Instructions:

All interested Respondents to this RFI are respectfully requested to complete the Attachment 0001 – Government’s Questions to Industry document and follow these document submission steps:

1. Complete Personal Identification Fields: Fill out all respondent/company information fields contained in Attachment 0001;
2. Convert the Attachment 00001 MS WORD document into an Adobe PDF document;
3. Digitally Sign and Date the Adobe PDF Document: Affix a digital signature and enter the date in the signature block;
4. Email the Completed and Signed Adobe PDF document: Send the signed/dated PDF document as an attachment to an email message addressed to:

• ATTN: Contract Specialist – John Overstake
• Email: john.overstake@va.gov
• Subject Line: “RFI Response – ETMPM/TENS Program – [Your Company’s Legal  Name]”; and
• Response Deadline: All responses to this RFI are due on or before, but no later than June 26, 2026 at 3:00 PM CST. Late submissions may not be reviewed and shall not receive a Government response.

Closing Remarks:

The Department of Veterans Affairs (VA) extends its deepest appreciation to all industry partners for their participation and heightened interest in the FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Program and the expanded Electro‑Therapeutic Modalities for Pain Management (ETMPM) Requirement.

The VA further acknowledges the professionalism and engagement demonstrated during the VA’s Industry Days held at the Denver Logistics Services (DLS) facility in Golden, Colorado from February 24–26, 2026. Your presence and contributions during these sessions reflect a meaningful and shared commitment to improving non‑opioid pain‑management solutions for this great nation’s Veterans.

The VA recognizes and values the time, energy, and thoughtful collaboration provided by prospective suppliers during this critical early phase of the acquisition process. Your awareness and industry expertise play an essential role in shaping a competitive, transparent, and well‑informed procurement environment that ensures America’s Veterans receive safe, reliable, clinically effective therapeutic devices that support their long‑term health and well‑being. The insights shared by industry partners are instrumental to the VA’s planning efforts, helping us refine requirements, enhance acquisition clarity, and uphold the highest standards of clinical readiness and supply chain resilience.

This procurement effort supports a solemn national promise reaffirmed through every VA program: “To care for those who have borne the battle in service to the United States.” The modernization of the TENS requirement and its strategic integration with advanced ETMPM technologies reflect the VA’s dedication to expanding evidence‑based, non-pharmacological modalities that directly enhance the quality of life for millions of Veterans living with acute and chronic pain conditions. Meeting this mission cannot occur without the dedication, capability, and integrity of committed private‑sector partners.

The Government sincerely appreciates industry’s continued engagement and the comprehensive market feedback received during this RFI stage. As this requirement progresses toward formal solicitation, we look forward to the ongoing partnership of qualified suppliers who share our commitment to delivering exceptional clinical tools, strengthening national logistics support, and honoring the sacrifice of those who served. Your continued collaboration enhances the VA’s ability to execute a timely, high‑quality, and mission‑aligned procurement process that will enable consistent access to critical pain‑management technologies across all VA medical facilities.

All future updates, timelines, and acquisition instructions will be communicated exclusively through the Governmentwide Point of Entry (GPE) at www.sam.gov. The Department of Veterans Affairs extends its sincere gratitude for your professionalism, attentiveness, and dedication to our Veterans. We value your partnership and look forward to your continued participation as this important requirement advances toward formal competition.